In Vitro Susceptibility of Gentamicin-Resistant Enterobacteriaceae and Pseudomonas aeruginosa to Netilmicin and Selected Aminoglycoside Antibiotics
AUTOR(ES)
Meyer, Richard D.
RESUMO
Netilmicin (Sch 20569), a semisynthetic aminoglycoside related to gentamicin C1a, was evaluated in vitro in agar dilution testing against 224 different clinical isolates of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa in parallel with amikacin, gentamicin, sisomicin, and tobramycin. Netilmicin showed a very high degree of activity against gentamicin-resistant organisms, but amikacin was more active in vitro, particularly against Providencia stuartii and P. aeruginosa. Sisomicin and tobramycin were consistently less active than either netilmicin or amikacin. Netilmicin was bactericidal in broth testing against P. aeruginosa. Netilmicin showed a greater difference between results with agar and broth dilution testing than did amikacin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=429813Documentos Relacionados
- Comparison of susceptibility of gentamicin-resistant and -susceptible "Acinetobacter anitratus" to 15 alternative antibiotics.
- Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria.
- In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.
- Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.
- Aminoglycoside Modification by Gentamicin-Resistant Isolates of Staphylococcus aureus
